Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2025-12-24 @ 4:19 PM
NCT ID:
NCT00527566
Eligibility Criteria:
Inclusion Criteria:
* Age \>18 years old
* Diagnosis of Churg Strauss Syndrome
* Maintained on stable corticosteroid dose of at least prednisone 10mg daily (or equivalent) prior to enrollment in study
* If on cyclophosphamide, azathioprine or methotrexate, must be on a stable dose and be able to maintain that dose for the duration of the study
Exclusion Criteria:
* Hypereosinophilic Syndrome
* Wegener's Granulomatosis
* Malignancy
* Parasitic Disease
* Pregnant or nursing
* If female and of child-bearing potential, must have negative pregnancy test prior to each infusion of study medication and must adhere to acceptable method of contraception (with \<1% failure rate)
* Any other medical illness that precludes study involvement
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT00527566
Study Brief:
Protocol Section:
NCT00527566